Photosensitizers and Reactive Oxygen Species for Photodynamic Cancer and Antimicrobial Therapy
This community develops light-activated molecules that generate reactive oxygen species to destroy cancer cells and pathogenic bacteria.
The research focuses on the synthesis, photophysical characterization, and biological application of photosensitizers, with a heavy emphasis on phthalocyanines, porphyrins, and BODIPY dyes. Key chemical motifs include zinc and boron difluoride complexes, often modified for near-infrared absorption to improve tissue penetration. The primary therapeutic targets are breast cancer, squamous cell carcinoma, and Staphylococcus aureus infections. A significant portion of the work investigates the mechanism of singlet oxygen generation and the resulting oxidative damage to cellular structures, alongside the development of 5-aminolevulinic acid-based approaches for endogenous photosensitizer accumulation.
The community is most prominent in oxygen research, accounting for 1.4% of all tracked oxygen studies, and boron research, where it represents 0.9% of the element's literature. It also constitutes 0.5% of zinc research.
The community comprises 28,885 papers, published primarily in Photodiagnosis and Photodynamic Therapy, Photochemistry and Photobiology, and the Journal of the American Chemical Society.
Recent work continues to explore nanoparticle-mediated antibacterial photodynamic therapy, the structural factors governing phthalocyanine activity, and the design of heavy-atom-free oligo-BODIPY photosensitizers for near-infrared applications.